湾区生物制药技术交流活动圆满落幕
《广东省发展生物医药与健康战略性支柱产业集群行动计划(2021-2025年)》中提出,要完善双核多节点产业空间布局,打造以广州、深圳为核心,以珠海、佛山、惠州、东莞、中山等为重点的产业创新集聚区,支持中山打造生物医药科技成果转化基地、生物医药科技国际合作创新区,大湾区生物制药产业日益活跃。
由中山火炬高技术产业开发区管理委员会、科创发展和投资促进局以及蒲公英(深圳)联合主办、中山市药学会承办的“湾区生物制药技术交流”活动,于2024年9月21日下午在中山市国家健康基地举办。本次活动邀请行业监管老师、企业代表、行业专家、服务链上下游以及制药企业代表共约50人出席。中山火炬高新技术开发区科技发展和投资促进局副局长周嘉华、中山市药学会秘书长徐亮致辞。


百济神州生产总监俞先旗给大家带来《制剂工艺优化及经验分享》演讲。

健康元集团质量总监罗时远针对“生物药品多产品同楼、多药品共线,委托生产的共线风险”进行了《药品委托生产共线风险评估管理策略》演讲,为大家解答共线难题。

云舟生物广州生产基地负责人姚中华进行了《生物制药CDMO厂房设计污染控制实践》,为生物制药工厂生物安全防护、控制污染风险带来灵感与实践思路。

河南省医药设计院总经理助理周春峰进行了《生物制药工厂布局原则探讨》演讲,对无菌控制措施与生物安全防护措施、VHP灭菌技术在生物安全领域的应用、制药项目设计过程中遇到的难点、洁净厂房施工管理过程中遇到的奇葩事儿、不建议共线生产案例等内容进行了分享。

演讲完毕,演讲嘉宾还与参会企业代表广东星昊药业有限公司总经理黄练昌、中山未名海济生物医药有限公司总经理王婉灵、联邦制药有限公司质量部经理万红彬等进行了圆桌对话,对企业遇到的实际问题进行了解答和交流。
这次活动促进了专家、企业间的合作与交流,为中山未来的生物制药创新发展奠定了基础。
中山市药学会
2024年9月23日
{"weixin":{"label":"微信","name":"weixin","selected":true,"value":true,"sortid":"1","shareid":"weixin","sharetitle":"分享到微信","event":"shareToWeiXin","lang":"shareWeb_WeiXin"},"copy":{"label":"复制网址","name":"copy","selected":true,"value":true,"sortid":"2","shareid":"copy","sharetitle":"复制网址","event":"copy_url","lang":"shareWeb_Copy"},"qq":{"label":"QQ好友","name":"qq","selected":true,"value":false,"sortid":"1","shareid":"qq","sharetitle":"分享到QQ","event":"shareToQQ","lang":"shareWeb_QQ"},"sina_weibo":{"label":"新浪微博","name":"sina_weibo","selected":true,"value":true,"sortid":"4","shareid":"sina_weibo","sharetitle":"分享到新浪微博","event":"shareToSinaWB","lang":"shareWeb_SinaWeiBo"},"qq_zone":{"label":"QQ空间","name":"qq_zone","selected":true,"value":true,"sortid":"5","shareid":"qq_zone","sharetitle":"分享到QQ空间","event":"shareToQzone","lang":"shareWeb_QQZone"},"renren":{"label":"人人网","name":"renren","selected":true,"value":false,"sortid":"7","shareid":"renren","sharetitle":"分享到人人网","event":"shareToRenren","lang":"shareWeb_RenRen"},"douban":{"label":"豆瓣网","name":"douban","selected":true,"value":true,"sortid":"8","shareid":"douban","sharetitle":"分享到豆瓣网","event":"shareToDouban","lang":"shareWeb_DouBan"},"baidu_tieba":{"label":"百度贴吧","name":"baidu_tieba","selected":true,"value":true,"sortid":"10","shareid":"baidu_tieba","sharetitle":"分享到百度贴吧","event":"shareToTieba","lang":"shareWeb_TieBa"},"Facebook":{"label":"Facebook","name":"Facebook","selected":true,"value":false,"sortid":"11","shareid":"Facebook","sharetitle":"分享到FaceBook","event":"shareToFacebook","lang":"shareWeb_Facebook"},"Twitter":{"label":"Twitter","name":"Twitter","selected":true,"value":false,"sortid":"12","shareid":"Twitter","sharetitle":"分享到Twitter","event":"shareToTwitter","lang":"shareWeb_Twitter"},"LinkedIn":{"label":"LinkedIn","name":"LinkedIn","selected":true,"value":false,"sortid":"13","shareid":"LinkedIn","sharetitle":"分享到linkedIn","event":"shareToLinkedin","lang":"shareWeb_Linkedin"},"whatsapp":{"label":"whatsapp","name":"whatsapp","selected":true,"value":false,"sortid":"15","shareid":"whatsapp","sharetitle":"分享到whatsapp","event":"shareToWhatsapp","lang":"shareWeb_whatsapp"},"line":{"label":"line","name":"line","selected":true,"value":false,"sortid":"15","shareid":"line","sharetitle":"分享到line","event":"shareToLine","lang":"shareWeb_line"},"qq_weibo":{"label":"腾讯微博","name":"qq_weibo","selected":true,"value":true,"sortid":"3","shareid":"qq_weibo","sharetitle":"分享到腾讯微博","event":"shareToQQwb","lang":"shareWeb_QQWeiBo"}}